Abstract:Objective To quantify the changes in blood glucose, blood lipids, blood pressure, and the intima-media thickness (IMT) of large arteries in patients with new-onset type 2 diabetes mellitus who received either intensive multifactorial treatment or conventional treatment. Methods Two-hundred and ten patients with new-onset type 2 diabetes mellitus were randomly assigned to two groups: an intensive treatment group ( n =110) and a conventional treatment group ( n =100). Fasting blood glucose (FBG), glycosylated hemoglobin A1c (HbA1c), blood pressure, blood lipids [total cholesterol (TC), triglyceride (TG), low-density lipoprotein C (LDL-C), and high-density lipoprotein C (HDL-C)], and IMTs of large arteries (carotid, iliac, and femoral arteries) were determined before and at one and two years after starting treatment. The patients in the conventional treatment group received routine diabetes management in our outpatient department. Targets were established for patients in the intensive treatment group. Their blood glucose, blood lipids, and blood pressure levels were regularly monitored and therapeutic regimens were adjusted for those whose measurements did not meet the target values until all the parameters met the established targets. Within-group and between-group differences were evaluated. Results A significantly greater percentage of patients in the intensive treatment group had LDL-C levels that reached the target value one year after starting treatment than those in the conventional treatment group (52.04% vs. 33.33%, P <0.05). No significant differences were found between groups for FBG, HbA1c, blood pressure, TG, TC, or HDL-C. The percentages of patients with TG (51.02% vs. 34.48%), TC (52.04% vs. 33.33%), and LDL-C (61.22% vs. 43.67%) who met the respective target values in the intensive treatment group were all significantly higher than the corresponding percentages in the conventional treatment group two years after starting treatment ( P <0.05). There were no significant differences in the percentages of patients with FBG, HbA1c, and blood pressure values meeting the respective targets between the groups at the two-year follow-up. One year after starting treatment, the LDL-C level, diastolic blood pressure (DBP), and the IMTs of the femoral and iliac arteries of the intensive treatment group were significantly lower compared to those of the conventional treatment group ( P <0.05), although there was no significant difference in other metabolic parameters. Two years after starting treatment, the TC, LDL-C, blood pressure [systolic blood pressure (SBP) and DBP], and the IMTs of the carotid and femoral arteries of the intensive treatment group were significantly lower than those of the conventional treatment group ( P <0.05). No significant differences in other metabolic parameters existed between the two groups two years after starting treatment. Conclusions Early comprehensive and intensive treatment of type 2 diabetes mellitus can delay or even reverse the increase in IMT of large arteries. Lowering blood pressure and blood lipid regulation in patients with type 2 diabetes mellitus have great significance in decreasing the risk of diabetes-related macrovascular lesions.

Characteristics of Lipid Profiles and Atherogenic Index of Plasma in Patients with Newly Diagnosed Type 2 Diabetes and Effect of Different Short-Term Intensive Hypoglycemic Interventions on Them

Effect of Intensive Multifactorial Treatment on the Intima-Media Thickness of Large Arteries in Patients with New-Onset Type 2 Diabetes Mellitus

Changes of Blood Pressure,blood Glucose and Blood Lipids Levels after Intensive Treatment in Incipient Diabetes II Patients

Subclinical atherosclerosis evaluated by high resolution ultrasonography in patients with newly diagnosed type 2 diabetes mellitus un-dergoing intensive treatment

Effect of Long-Term Integrated Intervention on Outcomes for Glucose Metabolism in Newly Diagnosed Type 2 Diabetic Patients

Effects of Short-Term Intensive Insulin Therapy on PancreaticβCell Functions and Serum Total Bile Acid Levels in Patients with Newly Diagnosed Type 2 Diabetes Mellitus

Effect of Intensive Insulin Therapy on Vascular Endothelial Function in Newly Diagnosed Type 2 Diabetes Patients

Comparison of the effect of different short-term intensive anti-diabetic therapies on newly diagnosed type 2 diabetic patients.

[The Effects of Early Intensive Therapy on Islet Beta Cell Function and Long-Term Glycemia Control in Newly Diagnosed Type 2 Diabetic Patients with Different Fasting Plasma Glucose Levels.].

Relationship Between Glycaemic Control and Lipid Profile in Chinese Patients with Type 2 Diabetes on Oral Antidiabetic Drugs Alone

[Features of Insulin Secretion and Insulin Resistance in Newly Diagnosed Type 2 Diabetes of Different Body Mass Indices].

The Clinical Outcome of Early Intensive Insulin Therapy in Newly Diagnosed Type 2 Diabetes

Effectiveness of Lifestyle Intervention in Patients with Type 2 Diabetes Mellitus

The Effect of Short-Term Intensive Insulin Therapy on Circulating T Cell Subpopulations in Patients with Newly Diagnosed Type 2 Diabetes Mellitus.

Integrated Intervention in Management of Type 2 Diabetes

Differential Therapeutic Effects of Nateglinide and Acarbose on Fasting and Postprandial Lipid Profiles: a Randomized Trial.

Induction of Long-Term Good Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients by Transient Intensive Insulin Treatment

Features of Insulin Secretion and Insulin Resistance in Chinese Newly-Diagnosed Type 2 Diabetes

[Influence of Short-Term Intensive Insulin Therapy on Plasma Concentration of Lipoprotein-Associated Phospholipase A(2) and Secretory Phospholipase A(2) in Newly Diagnosed Type 2 Diabetic Patients].

The Longitudinal Effect of the Atherogenic Index of Plasma on Type 2 Diabetes in Middle-Aged and Older Chinese

Early-stage Atherosclerosis in Newly Diagnosed, Untreated Type 2 Diabetes Mellitus and Impaired Glucose Tolerance